PFBT
CYTK icon

Parkside Financial Bank & Trust’s Cytokinetics CYTK Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17K Buy
258
+5
+2% +$318 ﹤0.01% 1370
2025
Q4 		$16.1K Buy
253
+38
+18% +$2.36K ﹤0.01% 1377
2025
Q3 		$11.8K Sell
215
-53
-20% -$2.18K ﹤0.01% 1458
2025
Q2 		$8.86K Buy
268
+53
+25% +$1.84K ﹤0.01% 1518
2025
Q1 		$8.64K Buy
+215
New +$9.88K ﹤0.01% 1456
2024
Q1 		– Sell
-22
Closed -$1.84K – 2045
2023
Q4 		$1.84K Sell
22
-260
-92% -$9.41K ﹤0.01% 1516
2023
Q3 		$8.31K Buy
282
+7
+3% +$233 ﹤0.01% 1182
2023
Q2 		$8.97K Hold
275
– – ﹤0.01% 1156
2023
Q1 		$9.68K Hold
275
– – ﹤0.01% 1119
2022
Q4 		$12.6K Hold
275
– – ﹤0.01% 985
2022
Q3 		$13K Hold
275
– – ﹤0.01% 916
2022
Q2 		$11K Hold
275
– – ﹤0.01% 964
2022
Q1 		$10K Hold
275
– – ﹤0.01% 1020
2021
Q4 		$13K Hold
275
– – ﹤0.01% 932
2021
Q3 		$10K Buy
275
+53
+24% +$1.56K ﹤0.01% 958
2021
Q2 		$4K Hold
222
– – ﹤0.01% 1302
2021
Q1 		$5K Hold
222
– – ﹤0.01% 1193
2020
Q4 		$5K Buy
222
+148
+200% +$2.71K ﹤0.01% 1098
2020
Q3 		$2K Hold
74
– – ﹤0.01% 1145
2020
Q2 		$2K Hold
74
– – ﹤0.01% 1149
2020
Q1 		$1K Hold
74
– – ﹤0.01% 1235
2019
Q4 		$1K Hold
74
– – ﹤0.01% 1355
2019
Q3 		$1K Hold
74
– – ﹤0.01% 1325
2019
Q2 		$1K Buy
+74
New +$714 ﹤0.01% 1343
2019
Q1 		– Sell
-76
Closed – – 1567
2018
Q4 		$0 Buy
+76
New +$558 ﹤0.01% 1475
2018
Q3 		– Sell
-44
Closed – – 1543
2018
Q2 		$0 Sell
44
-24
-35% -$200 ﹤0.01% 1542
2018
Q1 		$0 Buy
+68
New +$583 ﹤0.01% 1458
2017
Q4 		– Sell
-14
Closed – – 1387
2017
Q3 		$0 Buy
+14
New +$191 ﹤0.01% 1406

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Parkside Financial Bank & Trust's CYTK Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Cytokinetics (CYTK) stake by 2% in Q1 2026, buying an estimated $318 and bringing the position to 258 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1370.

Parkside Financial Bank & Trust first reported a position in CYTK in Q3 2017 and has held it in 28 quarters since. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Parkside Financial Bank & Trust held 258 shares of Cytokinetics worth $17K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 5 Cytokinetics shares in Q1 2026, an estimated $318.
  • Cytokinetics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1370 holding.
  • Parkside Financial Bank & Trust first reported a position in Cytokinetics in Q3 2017 and has held it in 28 quarters since.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.